News | CellFree Sciences

header jp

header en


Product information on Wheat germ CellFree Protein "Dialysis Synthesis" kit is now available.

Category: Articles Created: Saturday, 09 March 2024

Product information for Wheat germ CellFree Protein Dialysis Synthesis Kit (WEPRO7240 Series Dialysis Core Kit) is now available.

  • WEPRO7240 Dialysis Kit (p/n CFS-D7)
  • WEPRO7240G Dialysis Kit (p/n CFS-D7G)
  • WEPRO7240H Dialysis Kit (p/n CFS-D7H)

         These kits are ideal for scale-up synthesis of Wheat germ CellFree protein synthesis in larger quantities and with higher efficiency.

Outlook for 2021 from CellFree Sciences

Category: Articles Created: Tuesday, 02 February 2021

Our outlook for 2021 written by Ozawa, the President and CEO of CellFree Sciences Co., Ltd., was published on the international industry journal MED TECH Outlook.


Please click here for details.

Reported in MED TECH Outlook.

Category: Articles Created: Friday, 28 August 2020

The international industry journal MED TECH Outlook reported on our company as a Top IN VITRO DIAGNOSTIC solution provider in APAC 2020.


For further details, Please click here.


Our company was featured on NHK news.

Category: Articles Created: Thursday, 12 September 2019

The research results of "Proteo-Science Center" at Ehime University were presented at the 17th Protein Island Matsuyama International Symposium held on August 11th. Our company was featured on NHK news on the same day.


For further details, Please click here.

Year-End Update and 2019 Outlook from CellFree Sciences

Category: Articles Created: Thursday, 20 December 2018

Thank you for working together with CFS in 2018! With the year ending, we all at CFS wish you and your families all the very best for a wonderful Holiday Season, and hope that joy, happiness, and success will follow you throughout the New Year.


It had been an exciting and challenging year for CFS as we moved our Yokohama facilities in July, which are now located at the Yokohama Bioindustry Center. Please refer to our homepage for the new contact information. Note that also our telephone and FAX numbers have changed.


Working under ISO 9001:2015 since the end of 2017, we have made additional efforts for our commitment to customer satisfaction and to provide quality products and services for your protein needs. This had not always been easy after changes to US regulations and an increasing number of random FDA inspections had caused delays on some of our US shipments. We are deeply sorry for these delays and the problems this had caused to some of our customers! Large efforts had been made to discuss the situation with different shipping and logistic companies to improve our shipping documents, or to arrange for secured shipments. We really hope that these efforts will reduce the problems with US shipments in 2019, though some issues at US customs are out of our control.


This year, we started our new homepage and provide more information on cell-free protein expression on our new Twitter account. Please follow us at @CFSciences for updates on CFS, our products and services, and new publications on the use of cell-free protein expression in general. We hope this service will encourage more researchers to consider cell-free protein expression methods for their research and development projects. As part of our commitment to support global health for the benefits of the people, we further keep on supporting projects in malaria research bringing our expression system to discovery projects. Results from one of those projects on serological markers for P. vivax are now freely available for download at bioRxiv ( This project had been supported by the Global Health Innovative Technology (GHIT) Fund of Japan.


We have also exciting plans for 2019 introducing new products and services for protein research! For easy testing of expression templates and small-scale protein expression, we will introduce at the beginning of 2019 the new Premium ONE Expression Kit. This kit will provide a new reaction format now using coupled transcription and translation reactions for quick and easy protein synthesis. In combination with template preparation by PCR, this kit will make it much easier for you to test expression from various templates or to prepare small amounts of proteins for your experiments. The kit will likewise provide the option to further prepare labeled proteins. Please contact us if you are interested in testing the new kit.


Use in large-scale protein expression experiments is one of the biggest advantages of the wheat germ cell-free system as compared to other products on the market. Therefore, we keep on working to provide better solutions for large-scale protein production. For next year, we plan to provide new products to support better the dialysis format for extended reaction times and higher protein yields. These products will become available later in 2019.


For many years, CFS has been producing a large-scale protein set comprising some 20,000 human proteins as part of joint research conducted together with AIST in Japan. We will now offer a new service using this protein set for Antibody Validation experiments. This service will allow you to test your antibodies for possible cross reactivity to other human proteins using a unique bead-array format. Please contact us for more information and an offer to test our new Antibody Validation Service.


Thank you once again for your loyalty and support. Please let us know if you have any suggestions, questions or needs for your research and development projects. Your feedback is important to us. We all at CFS are looking forward to keeping on being at your service also in 2019 and to support your important projects with our products and services.


Copyright © CellFree Sciences Co.,Ltd. All Rights Reserved. [login]

We use cookies to ensure you get the best experience. By using our website you agree to our Cookie Policy.